|
| 34090740 | The Controversy of Pepsinogen A/Pepsin A in Detecting Extra-Gastroesophageal Reflux. | J Voice | 2023 |
| 37633678 | Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. | Lancet Public Health | 2023 |
| 37490292 | Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial. | JAMA Netw Open | 2023 |
| 37704538 | Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. | Clin Colorectal Cancer | 2023 |
| 37744308 | Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With <i>MET</i> Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies. | JTO Clin Res Rep | 2023 |
| 37504341 | Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience. | Curr Oncol | 2023 |
| 37738239 | Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. | PLoS Genet | 2023 |
| 37574132 | Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial. | J Thorac Oncol | 2023 |
| 37573276 | Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis. | Adv Ther | 2023 |
| 37599055 | Re: Response to Letter to the Editor "Respiratory and Cardiometabolic Comorbidities and Stage I-III Non-Small Cell Lung Cancer (NSCLC) Survival: A Pooled Analysis From the International Lung Cancer Consortium". | J Thorac Oncol | 2023 |
| 35634745 | Gastrointestinal Dysmotility as the First Manifestation of Myasthenia Gravis. | Can J Neurol Sci | 2023 |
| 37423228 | First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. | Lancet | 2023 |
| 37150255 | Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. | J Thorac Oncol | 2023 |
| 36944282 | Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations. | Lung Cancer | 2023 |
| 37341839 | Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study. | Support Care Cancer | 2023 |
| 37243515 | Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer Patients. | Nutr Cancer | 2023 |
| 37338962 | Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions. | Stat Methods Med Res | 2023 |
| 37236969 | Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. | Nat Commun | 2023 |
| 37306090 | Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer. | Future Oncol | 2023 |
| 37168566 | DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection. | iScience | 2023 |
| 36998123 | A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes. | Stat Med | 2023 |
| 37471639 | Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. | Hum Mol Genet | 2023 |
| 36653915 | Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. | Cancer | 2023 |
| 36694401 | A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. | Int J Cancer | 2023 |
| 36404465 | Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. | Ann Epidemiol | 2023 |
| 36811599 | Proliferative exhausted CD8<sup>+</sup> T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma. | Elife | 2023 |
| 36877099 | TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i>-positive non-small-cell lung cancer and other solid tumors. | Future Oncol | 2023 |
| 36688707 | Use of artificial intelligence for cancer clinical trial enrollment: a systematic review and meta-analysis. | J Natl Cancer Inst | 2023 |
| 36396063 | Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. | J Thorac Oncol | 2023 |
| 36535627 | Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model. | J Thorac Oncol | 2023 |
| 36535300 | Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study. | Lancet Respir Med | 2023 |
| 36930839 | Using Recurrent Neural Networks to Extract High-Quality Information From Lung Cancer Screening Computerized Tomography Reports for Inter-Radiologist Audit and Feedback Quality Improvement. | JCO Clin Cancer Inform | 2023 |
| 36827626 | Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study. | J Clin Oncol | 2023 |
| 36631713 | Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma. | Esophagus | 2023 |
| 36416855 | Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 36862481 | Promoting Self-management and Patient Activation Through eHealth: Protocol for a Systematic Literature Review and Meta-analysis. | JMIR Res Protoc | 2023 |
| 36214668 | Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer. | Mol Cancer Res | 2023 |
| 36270866 | Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. | Clin Lung Cancer | 2023 |
| 36348098 | The role of HPV status in patients with overlapping grey zone cancer in oral cavity and oropharynx. | Eur Arch Otorhinolaryngol | 2023 |
| 36281472 | Clustering on longitudinal quality-of-life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial. | Cancer Med | 2023 |
| 34531139 | Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. | Clin Lung Cancer | 2022 |
| 35383171 | Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes. | Nat Commun | 2022 |
| 35709760 | eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35801270 | Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. | Head Neck | 2022 |
| 35605188 | Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With <i>ALK</i>-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study. | J Clin Oncol | 2022 |
| 35500836 | A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. | J Thorac Oncol | 2022 |
| 35719866 | Automating Access to Real-World Evidence. | JTO Clin Res Rep | 2022 |
| 35660971 | Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial. | Lung Cancer | 2022 |
| 36439025 | Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts. | Cancer Inform | 2022 |
| 36425756 | Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction. | iScience | 2022 |